Jolkinolide B alleviates renal fibrosis via anti-inflammation and inhibition of epithelial-mesenchymal transition in unilateral ureteral obstruction mice

The global burden of chronic kidney disease

(2020) Paul Cockwell et al.   LANCET

Diverse Role of TGF-β in Kidney Disease

(2020) Yue-Yu Gu et al.   Frontiers in Cell and Developmental Biology

Targeting the progression of chronic kidney disease

(2020) Marta Ruiz-Ortega et al.   Nature Reviews Nephrology

New Insights Into the Role and Mechanism of Partial Epithelial-Mesenchymal Transition in Kidney Fibrosis

(2020) Lili Sheng et al.   Frontiers in Physiology

Chronic kidney disease: Biomarker diagnosis to therapeutic targets

(2019) Yan-Ni Wang et al.   CLINICA CHIMICA ACTA

Inflammation and renal fibrosis: Recent developments on key signaling molecules as potential therapeutic targets

(2018) Wenshan Lv et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Protective effect of Jolkinolide B on LPS-induced mouse acute lung injury

(2015) Hailing Yang et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Targeting EMT to reverse renal fibrosis

(2015) Susan J. Allison   Nature Reviews Nephrology

Jolkinolide B inhibits RANKL-induced osteoclastogenesis by suppressing the activation NF-κB and MAPK signaling pathways

(2014) Xiaojun Ma et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Inflammatory processes in renal fibrosis

(2014) Xiao-Ming Meng et al.   Nature Reviews Nephrology

Chronic kidney disease: global dimension and perspectives

(2013) Vivekanand Jha et al.   LANCET

The role of EMT in renal fibrosis

(2011) Rosemarie M. Carew et al.   CELL AND TISSUE RESEARCH

Chemical Constituents and Biological Activities of Euphorbia fischerianaSteud.

(2011) Yong-Xu Sun et al.   CHEMISTRY & BIODIVERSITY

17-Hydroxy-jolkinolide B, a diterpenoid from Euphorbia fischeriana, inhibits inflammatory mediators but activates heme oxygenase-1 expression in lipopolysaccharide-stimulated murine macrophages

(2011) Takuhiro Uto et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Blockade of Endothelial-Mesenchymal Transition by a Smad3 Inhibitor Delays the Early Development of Streptozotocin-Induced Diabetic Nephropathy

(2010) J. Li et al.   DIABETES

NF- B in Renal Inflammation

(2010) A. B. Sanz et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY